Author: Burkert, Francesco Robert; Niederreiter, Lukas; Dichtl, Wolfgang; Mayr, Agnes; Virgolini, Irene; Klauser, Andrea; Weiss, Günter; Bellmann-Weiler, Rosa
Title: Case report of a COVID-19-associated myocardial infarction with no obstructive coronary arteries: the mystery of the phantom embolus or local endothelitis Cord-id: lp3t1v1i Document date: 2021_1_6
ID: lp3t1v1i
Snippet: BACKGROUND: Since the first documented outbreak of a novel severe acute respiratory syndrome inducing Coronavirus in China at the end of 2019 the virus has spread to all continents, leading the WHO to declare a pandemic in March 2020. While this virus primarily targets the alveoli in the lungs, multiple authors have described an increased rate of thrombo-embolic events in affected patients. We present this case of a myocardial infarction with no obstructive coronary atherosclerosis in an otherwi
Document: BACKGROUND: Since the first documented outbreak of a novel severe acute respiratory syndrome inducing Coronavirus in China at the end of 2019 the virus has spread to all continents, leading the WHO to declare a pandemic in March 2020. While this virus primarily targets the alveoli in the lungs, multiple authors have described an increased rate of thrombo-embolic events in affected patients. We present this case of a myocardial infarction with no obstructive coronary atherosclerosis in an otherwise healthy 48-year-old patient. CASE SUMMARY: A 48-year-old female, presenting with chest pain radiating to her left shoulder with no cardiovascular risk factors other than genetic predisposition, was screened for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and tested positive. Although computed tomography angiography excluded obstructive coronary heart disease, cardiac magnetic resonance imaging showed an acute myocardial infarction with no obstructive coronary arteries of the inferior wall. The patient was treated with dual anti-platelet therapy, an angiotensin-converting-enzyme inhibitor and a statin, and assigned to a cardiac rehabilitation program. CONCLUSION: We report a serious thrombo-embolic event during an oligosymptomatic SARS-CoV-2 infection in a healthy, young patient. While these two diseases may have occurred simultaneously, by chance, it is possible that the pro-thrombotic effects of the SARS-CoV-2 infection facilitated the infarction. This case further demonstrates the significant cardiovascular morbidity potentially caused by SARS-CoV-2.
Search related documents:
Co phrase search for related documents- acetylsalicylic acid and acute respiratory: 1, 2, 3, 4, 5
- acetylsalicylic acid and low molecular weight: 1, 2, 3, 4, 5
- acetylsalicylic acid and low molecular weight heparin: 1, 2, 3, 4
- acetylsalicylic acid and magnetic resonance: 1, 2, 3, 4
- acetylsalicylic acid therapy and magnetic resonance: 1
- acute cardiac event and magnetic resonance: 1
- acute myocardial infarction and low molecular weight: 1, 2, 3
- acute myocardial infarction and low molecular weight heparin: 1, 2, 3
- acute myocardial infarction and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute respiratory and local presentation: 1, 2, 3, 4
- acute respiratory and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory and lung affect: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- low molecular weight and lung affect: 1, 2
- low molecular weight and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8
- low molecular weight heparin and lung affect: 1
- low molecular weight heparin and magnetic resonance: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date